HUTCHMED (China) (HCM) Total Non-Current Liabilities (2015 - 2025)
HUTCHMED (China) (HCM) reported Total Non-Current Liabilities of $51.3 million for Q4 2025, down 16.87% year-over-year from $61.7 million in Q4 2024, and down 88.36% quarter-over-quarter from $441.0 million in Q2 2025.
HUTCHMED (China) (HCM) Total Non-Current Liabilities (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Total Non-Current Liabilities data on file, last reported at $51.3 million in Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $51.3 million, down 16.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $51.3 million (down 16.87% YoY), and the FY2025 annual result was $5.0 million, up 28.69% from the prior year.
- Total Non-Current Liabilities fell to $51.3 million in Q4 2025 per HCM's latest filing, from $441.0 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $441.0 million in Q2 2025 and troughed at -$2.8 billion in Q4 2023.
- A 5-year average of -$118.2 million and a median of $61.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities jumped 774.28% in 2021, then plunged 6148.6% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $35.8 million in 2021, then surged by 31.16% to $47.0 million in 2022, then slumped by 6148.6% to -$2.8 billion in 2023, then surged by 102.17% to $61.7 million in 2024, then slipped by 16.87% to $51.3 million in 2025.
- Business Quant data shows HCM's Total Non-Current Liabilities at $51.3 million in Q4 2025, $441.0 million in Q2 2025, and $61.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | 51.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.32 Mn |
| Jun 30, 2025 | 440.98 Mn |
| Dec 31, 2024 | 61.74 Mn |
| Jun 30, 2024 | 61.85 Mn |
| Dec 31, 2023 | -2.84 Bn |
| Jun 30, 2023 | 44.16 Mn |
| Dec 31, 2022 | 46.96 Mn |
| Jun 30, 2022 | 322.27 Mn |
| Dec 31, 2021 | 35.81 Mn |
| Jun 30, 2021 | 253.67 Mn |
| Mar 31, 2021 | 221.92 Mn |
| Dec 31, 2020 | 6.74 Mn |
| Jun 30, 2020 | -37.62 Mn |
| Dec 31, 2019 | 48.69 Mn |
| Sep 30, 2019 | 108.85 Mn |
| Jun 30, 2019 | 114.32 Mn |
| Mar 31, 2019 | 130.61 Mn |
| Dec 31, 2018 | 117.46 Mn |
| Jun 30, 2018 | 117.25 Mn |
| Dec 31, 2017 | -18.75 Mn |